Bacil Pharma Ltd Balance Sheet: Consolidated Financial Analysis & Historical Data (15 Years)

Annual Results

Results Snapshot

Figures in Cr

Standalone - Balance Sheet Results

Mar'25

Mar'24

Mar'23

Mar'22

Mar'21

Mar'20

Balance Sheet Analysis Highlights

Borrowings

YoY Growth in year ended Mar 2025 is 60.00% vs 400.00% in Mar 2024

Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods;

Fixed Assets

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

Investments

YoY Growth in year ended Mar 2025 is 3,401.64% vs 154.17% in Mar 2024

Current Assets

YoY Growth in year ended Mar 2025 is 5,720.00% vs -78.26% in Mar 2024

Compare Balance Sheet Results of Bacil Pharma

Select Peers

Figures in Cr

Standalone - Balance Sheet Results

Change(INR)

Change(%)

No of Months

EQUITY AND LIABILITIES

Share Capital

13.97

16.27

-2.30

-14.14%

Share Warrants & Outstandings

Total Reserve

11.46

2.51

8.95

356.57%

Shareholder's Funds

25.43

18.78

6.65

35.41%

Minority Interest

0.00

0.00%

Long-Term Borrowings

0.00

0.00%

Secured Loans

0.00

0.00%

Unsecured Loans

0.00

0.00%

Deferred Tax Assets / Liabilities

-0.05

0.33

-0.38

-115.15%

Other Long Term Liabilities

0.00

0.00%

Long Term Trade Payables

0.00

0.00%

Long Term Provisions

0.00

0.00%

Total Non-Current Liabilities

-0.05

0.33

-0.38

-115.15%

Current Liabilities

Trade Payables

0.00

30.99

-30.99

-100.00%

Other Current Liabilities

0.00

0.18

-0.18

-100.00%

Short Term Borrowings

0.16

0.47

-0.31

-65.96%

Short Term Provisions

0.00

0.21

-0.21

-100.00%

Total Current Liabilities

0.17

31.85

-31.68

-99.47%

Total Liabilities

25.55

50.96

-25.41

-49.86%

ASSETS

Non-Current Assets

0.00

0.00%

Gross Block

0.06

11.75

-11.69

-99.49%

Less: Accumulated Depreciation

0.06

3.41

-3.35

-98.24%

Less : Impairment of Assets

0.00

0.00%

Net Block

0.00

8.34

-8.34

-100.00%

Lease Adjustment

0.00

0.00%

Capital Work in Progress

0.00

0.00%

Intangible assets under development

0.00

0.00%

Pre-operative Expenses pending

0.00

0.00%

Assets in transit

0.00

0.00%

Non Current Investments

21.36

0.00

21.36

0.00%

Long Term Loans & Advances

1.28

0.00

1.28

0.00%

Other Non Current Assets

0.00

0.06

-0.06

-100.00%

Total Non-Current Assets

22.64

8.41

14.23

169.20%

Current Assets Loans & Advances

Current Investments

0.00

0.00%

Inventories

0.00

3.34

-3.34

-100.00%

Sundry Debtors

0.00

38.31

-38.31

-100.00%

Cash and Bank

2.86

0.26

2.60

1,000.00%

Other Current Assets

0.00

0.05

-0.05

-100.00%

Short Term Loans and Advances

0.05

0.59

-0.54

-91.53%

Total Current Assets

2.91

42.55

-39.64

-93.16%

Net Current Assets (Including Current Investments)

2.74

10.71

-7.97

-74.42%

Total Current Assets Excluding Current Investments

2.91

42.55

-39.64

-93.16%

Miscellaneous Expenses not written off

0.00

0.00%

Total Assets

25.55

50.96

-25.41

-49.86%

Contingent Liabilities

0.00

0.00%

Total Debt

0.16

0.47

-0.31

-65.96%

Book Value per share (adjusted)

18.20

11.54

6.66

57.71%

Annual - Borrowings

Borrowings 0.16 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 60.00% vs 400.00% in Mar 2024

Annual - Other Long Term Liabilities

No Other Long Term Liabilities in the last few periods

No Other Long Term Liabilities in the last few periods;

Annual - Fixed Assets

Fixed Assets 0.00 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is -100.00% vs 0.00% in Mar 2024

Annual - Investments

Investments 21.36 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 3,401.64% vs 154.17% in Mar 2024

Annual - Current Assets

Current Assets 2.91 Cr

in Mar 2025

Figures in Cr

YoY Growth in year ended Mar 2025 is 5,720.00% vs -78.26% in Mar 2024